Molecule could help treat insulin resistance

Diabetes Call for further research into apelin treatment in diabetes after positive results in mice.

Insulin resistance in diabetes and other metabolic disorders could be treated by a naturally occurring molecule with insulin-like effects, studies by French researchers suggest.

The mechanisms that regulate apelin, a peptide found in a variety of tissues in the body and in the bloodstream, and those that regulate insulin are known to be closely related, but researchers had not previously looked at how apelin affects glucose metabolism in the body.

Professor Isabelle Castan-Laurell and colleagues from the University of Toulouse injected mice intravenously with apelin and found that it rapidly reduced glucose levels in the blood.

They then went on to examine how apelin affected the way that glucose was metabolised in the body. They found that apelin increased glucose turnover and, in response, liver tissue adjusted its glucose production so that normal blood glucose levels were maintained.

In addition, apelin was able to increase insulin-stimulated glucose transport, suggesting that the effects of apelin and insulin are mediated by different mechanisms and can be additive.

'Apelin could represent a promising target in the management of insulin resistance,' Professor Castan-Laurell said.

'Improvement of insulin sensitivity and reduction of blood glucose levels are expected goals for the treatment of type-2 diabetes. We demonstrated that acute injection of apelin was able to improve glucose tolerance in insulin-resistant mice and to increase glucose utilisation in white adipose tissue, skeletal muscles and the heart.'

The effect of long-term treatment with apelin will now need to be studied to provide further insight into the precise role the peptide plays in treating insulin resistance, the researchers said.

The findings may also have wider benefits, they pointed out. 'The contribution of apelin should yield new insights into the physiology and physiopathology of glucose and lipid metabolism.'

tom.moberly@haymarket.com

Cell Metabolism 2008; 8: 437-45

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...

Medeconomics Live aims to help practices thrive under the new GP contract

Medeconomics Live aims to help practices thrive under the new GP contract

The one-day, virtual Medeconomics Live conference aims to provide practices with...

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GP practices have faced a wave of abuse and complaints after a letter from NHS England...

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

The government has denied plans to make GPs 'gatekeepers' of the struggling COVID-19...